Ocular Melanoma Research

See also: Eye Cancer and Ocular Oncology Team

Ophthalmic pathologist, Hans Grossniklaus, MD, MBA, is working with mice to explore new methods of treating ocular melanoma, which occurs in about 5 to 10 percent of all melanoma patients. Since mice have immune systems that fight melanoma cells, this research may one day lead to a melanoma vaccine or gene therapy to treat the disease.